LORI WILEY: Open Payments
NPI 1013362672 · BRAZIL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 28 payments from 5 companies in 2025. Trend: 2023 $307 · 2024 $409 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 17 | $211 |
| Vanda Pharmaceuticals Inc. | 4 | $74 |
| Braeburn Inc. | 3 | $60 |
| Indivior Inc. | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
Products named: REXULTI, FANAPT, BRIXADI, SUBLOCADE, CAPLYTA.
Industry payments across IN — which companies pay providers there.
